{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:43:58Z","timestamp":1791942238483,"version":"4.3.4"},"reference-count":258,"publisher":"The Endocrine Society","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,12,1]]},"DOI":"10.1210\/er.2017-00062","type":"journal-article","created":{"date-parts":[[2017,8,4]],"date-time":"2017-08-04T14:08:56Z","timestamp":1501855736000},"page":"489-515","source":"Crossref","is-referenced-by-count":290,"title":["New Perspectives on Pheochromocytoma and Paraganglioma: Toward a Molecular Classification"],"prefix":"10.1210","volume":"38","author":[{"given":"Joakim","family":"Crona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Ta\u00efeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","published-online":{"date-parts":[[2017,8,4]]},"reference":[{"issue":"6","key":"key\n\t\t\t\t20171205135818_B1","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Endocrine Society","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrc3648","article-title":"Pheochromocytoma and paraganglioma pathogenesis: learning from genetic heterogeneity","volume":"14","year":"2014","journal-title":"Nat Rev Cancer"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B3","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Cancer Genome Atlas Research Network","year":"2017","journal-title":"Cancer Cell"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrendo.2014.188","article-title":"Paraganglioma and phaeochromocytoma: from genetics to personalized medicine","volume":"11","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"key\n\t\t\t\t20171205135818_B5","first-page":"169","article-title":"Familial paragangliomas","volume-title":"Hered Cancer Clin Pract","year":"2006"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B6","first-page":"802","article-title":"Occurrence of pheochromocytoma in Rochester, Minnesota, 1950 through 1979","volume":"58","year":"1983","journal-title":"Mayo Clin Proc"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B7","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.0954-6820.1986.tb02755.x","article-title":"Pheochromocytoma in Sweden 1958\u20131981. An analysis of the National Cancer Registry Data","volume":"220","year":"1986","journal-title":"Acta Med Scand"},{"key":"key\n\t\t\t\t20171205135818_B8","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1196\/annals.1353.003","article-title":"Characteristics of pheochromocytoma in a 4- to 20-year-old population","volume":"1073","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B9","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1007\/s00268-004-7134-9","article-title":"Pheochromocytoma surgery: epidemiologic peculiarities in children","volume":"28","year":"2004","journal-title":"World J Surg"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B10","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s002689900139","article-title":"Clinical spectrum and outcome of functional extraadrenal paraganglioma","volume":"20","year":"1996","journal-title":"World J Surg"},{"issue":"34","key":"key\n\t\t\t\t20171205135818_B11","doi-asserted-by":"crossref","first-page":"8812","DOI":"10.1200\/JCO.2005.03.1484","article-title":"Genetic testing in pheochromocytoma or functional paraganglioma","volume":"23","year":"2005","journal-title":"J Clin Oncol"},{"issue":"31","key":"key\n\t\t\t\t20171205135818_B12","doi-asserted-by":"crossref","first-page":"4137","DOI":"10.1200\/JCO.2011.34.6353","article-title":"Metastatic pheochromocytoma\/paraganglioma related to primary tumor development in childhood or adolescence: significant link to SDHB mutations","volume":"29","year":"2011","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171205135818_B13","first-page":"479","volume-title":"Adrenal disorders","year":"2001"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B14","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1002\/jso.23297","article-title":"Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades","volume":"107","year":"2013","journal-title":"J Surg Oncol"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B15","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.humpath.2009.12.005","article-title":"Immunohistochemistry for SDHB triages genetic testing of SDHB, SDHC, and SDHD in paraganglioma-pheochromocytoma syndromes","volume":"41","year":"2010","journal-title":"Hum Pathol"},{"issue":"8","key":"key\n\t\t\t\t20171205135818_B16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.292.8.943","article-title":"Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations","volume":"292","author":"European-American Paraganglioma Study Group","year":"2004","journal-title":"JAMA"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B17","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2008-2419","article-title":"Clinically guided genetic screening in a large cohort of Italian patients with pheochromocytomas and\/or functional or nonfunctional paragangliomas","volume":"94","author":"Italian Pheochromocytoma\/Paraganglioma Network","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B18","doi-asserted-by":"crossref","first-page":"e86756","DOI":"10.1371\/journal.pone.0086756","article-title":"Integrative genetic characterization and phenotype correlations in pheochromocytoma and paraganglioma tumours","volume":"9","year":"2014","journal-title":"PLoS One"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B19","doi-asserted-by":"crossref","first-page":"E1352","DOI":"10.1210\/jc.2013-4375","article-title":"Rare germline mutations identified by targeted next-generation sequencing of susceptibility genes in pheochromocytoma and paraganglioma","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B20","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1093\/hmg\/ddt639","article-title":"Germline mutations in FH confer predisposition to malignant pheochromocytomas and paragangliomas","volume":"23","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B21","doi-asserted-by":"crossref","first-page":"E2046","DOI":"10.1210\/jc.2014-1659","article-title":"Germline FH mutations presenting with pheochromocytoma","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B22","first-page":"302","article-title":"Characteristics and outcomes of metastatic SDHB and sporadic pheochromocytoma\/paraganglioma: an NIH study","volume":"22","year":"2015","journal-title":"Endocr Pract"},{"key":"key\n\t\t\t\t20171205135818_B23","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jc.2010-1946","article-title":"Clinical risk factors for malignancy and overall survival in patients with pheochromocytomas and sympathetic paragangliomas: primary tumor size and primary tumor location as prognostic indicators","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B24","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1210\/jc.2008-2756","article-title":"Genetics of pheochromocytoma and paraganglioma in Spanish patients","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.2165\/11530430-000000000-00000","article-title":"Clinical experience with pheochromocytoma in a single centre over 16 years","volume":"16","year":"2009","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"20","key":"key\n\t\t\t\t20171205135818_B26","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1093\/hmg\/ddr324","article-title":"Integrative genomic analysis reveals somatic mutations in pheochromocytoma and paraganglioma","volume":"20","year":"2011","journal-title":"Hum Mol Genet"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B27","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1007\/s00268-012-1430-6","article-title":"Prevalence of germline mutations in patients with pheochromocytoma or abdominal paraganglioma and sporadic presentation: a population-based study in western Sweden","volume":"36","year":"2012","journal-title":"World J Surg"},{"issue":"17","key":"key\n\t\t\t\t20171205135818_B28","first-page":"5615","article-title":"Mutations in the SDHB gene are associated with extra-adrenal and\/or malignant phaeochromocytomas","volume":"63","author":"COMETE Network","year":"2003","journal-title":"Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1530\/ERC-13-0415","article-title":"Long-term prognosis of patients with pediatric pheochromocytoma","volume":"21","year":"2013","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B30","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1053\/jpsu.2001.21612","article-title":"Pheochromocytoma in children","volume":"36","year":"2001","journal-title":"J Pediatr Surg"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B31","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1677\/ERC-08-0049","article-title":"Metastases but not cardiovascular mortality reduces life expectancy following surgical resection of apparently benign pheochromocytoma","volume":"15","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20171205135818_B32","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1196\/annals.1353.048","article-title":"Mortality associated with pheochromocytoma: increased risk for additional tumors","volume":"1073","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B33","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.ecl.2006.09.014","article-title":"Emergencies caused by pheochromocytoma, neuroblastoma, or ganglioneuroma","volume":"35","year":"2006","journal-title":"Endocrinol Metab Clin North Am"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B34","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archotol.124.10.1133","article-title":"Vagal paraganglioma: a review of 46 patients treated during a 20-year period","volume":"124","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"key\n\t\t\t\t20171205135818_B35","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1210\/jc.2007-0709","article-title":"Succinate dehydrogenase B gene mutations predict survival in patients with malignant pheochromocytomas or paragangliomas","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B36","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1530\/EJE-12-0968","article-title":"Quality of life is decreased in patients with paragangliomas","volume":"168","year":"2013","journal-title":"Eur J Endocrinol"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B37","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/ejhg.2015.36","article-title":"No evidence for increased mortality in SDHD variant carriers compared with the general population","volume":"23","year":"2015","journal-title":"Eur J Hum Genet"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1210\/jc.2012-3669","article-title":"Is the excess cardiovascular morbidity in pheochromocytoma related to blood pressure or to catecholamines","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"key\n\t\t\t\t20171205135818_B39","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.1210\/jc.2008-2697","article-title":"Survival of patients with metastatic malignant pheochromocytoma and efficacy of combined cyclophosphamide, vincristine, and dacarbazine chemotherapy","volume":"94","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B40","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","article-title":"Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis","volume":"49","year":"2012","journal-title":"J Med Genet"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B41","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1210\/er.2014-1026","article-title":"Current approaches and recent developments in the management of head and neck paragangliomas","volume":"35","year":"2014","journal-title":"Endocr Rev"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1136\/jmedgenet-2016-104058","article-title":"Survival and causes of death in patients with von Hippel\u2013Lindau disease","volume":"54","year":"2017","journal-title":"J Med Genet"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B43","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"15","key":"key\n\t\t\t\t20171205135818_B44","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1093\/hmg\/ddq206","article-title":"SDHA is a tumor suppressor gene causing paraganglioma","volume":"19","year":"2010","journal-title":"Hum Mol Genet"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1086\/321282","article-title":"Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma","volume":"69","year":"2001","journal-title":"Am J Hum Genet"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B46","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/81551","article-title":"Mutations in SDHC cause autosomal dominant paraganglioma, type 3","volume":"26","year":"2000","journal-title":"Nat Genet"},{"issue":"5454","key":"key\n\t\t\t\t20171205135818_B47","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1126\/science.287.5454.848","article-title":"Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma","volume":"287","year":"2000","journal-title":"Science"},{"key":"key\n\t\t\t\t20171205135818_B48","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.1175689","article-title":"SDH5, a gene required for flavination of succinate dehydrogenase, is mutated in paraganglioma","volume":"325","year":"2009","journal-title":"Science"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B49","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.ccr.2013.04.018","article-title":"SDH mutations establish a hypermethylator phenotype in paraganglioma","volume":"23","year":"2013","journal-title":"Cancer Cell"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B50","first-page":"107","article-title":"Whole-exome sequencing identifies MDH2 as a new familial paraganglioma gene","volume":"107","year":"2015","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ccr.2004.11.022","article-title":"Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase","volume":"7","year":"2005","journal-title":"Cancer Cell"},{"issue":"5112","key":"key\n\t\t\t\t20171205135818_B52","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1126\/science.8493574","article-title":"Identification of the von Hippel\u2013Lindau disease tumor suppressor gene","volume":"260","year":"1993","journal-title":"Science"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1399-0004.2007.00827.x","article-title":"Frequency of Von Hippel\u2013Lindau germline mutations in classic and non-classic Von Hippel\u2013Lindau disease identified by DNA sequencing, Southern blot analysis and multiplex ligation-dependent probe amplification","volume":"72","year":"2007","journal-title":"Clin Genet"},{"issue":"17","key":"key\n\t\t\t\t20171205135818_B54","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1093\/jnci\/djt201","article-title":"Hypoxia-inducible factor signaling in pheochromocytoma: turning the rudder in the right direction","volume":"105","year":"2013","journal-title":"J Natl Cancer Inst"},{"key":"key\n\t\t\t\t20171205135818_B55","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1056\/NEJMoa1205119","article-title":"Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"issue":"13","key":"key\n\t\t\t\t20171205135818_B56","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1200\/JCO.2012.47.1912","article-title":"New syndrome of paraganglioma and somatostatinoma associated with polycythemia","volume":"31","year":"2013","journal-title":"J Clin Oncol"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B57","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.neo.2016.07.008","article-title":"Hypoxia-inducible factor 2\u03b1 mutation-related paragangliomas classify as discrete pseudohypoxic subcluster","volume":"18","year":"2016","journal-title":"Neoplasia"},{"issue":"25","key":"key\n\t\t\t\t20171205135818_B58","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1056\/NEJMoa0806277","article-title":"PHD2 mutation and congenital erythrocytosis with paraganglioma","volume":"359","year":"2008","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B59","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00109-014-1205-7","article-title":"Germ-line PHD1 and PHD2 mutations detected in patients with pheochromocytoma\/paraganglioma-polycythemia","volume":"93","year":"2015","journal-title":"J Mol Med (Berl)"},{"issue":"6428","key":"key\n\t\t\t\t20171205135818_B60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/363458a0","article-title":"Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A","volume":"363","year":"1993","journal-title":"Nature"},{"issue":"5196","key":"key\n\t\t\t\t20171205135818_B61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1126\/science.7824936","article-title":"Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B","volume":"267","year":"1995","journal-title":"Science"},{"issue":"4965","key":"key\n\t\t\t\t20171205135818_B62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1126\/science.2134734","article-title":"Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients","volume":"249","year":"1990","journal-title":"Science"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ng.533","article-title":"Germline mutations in TMEM127 confer susceptibility to pheochromocytoma","volume":"42","year":"2010","journal-title":"Nat Genet"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ng.861","article-title":"Exome sequencing identifies MAX mutations as a cause of hereditary pheochromocytoma","volume":"43","year":"2011","journal-title":"Nat Genet"},{"issue":"25","key":"key\n\t\t\t\t20171205135818_B65","doi-asserted-by":"crossref","first-page":"19297","DOI":"10.1074\/jbc.M905866199","article-title":"Signaling through Ras is essential for ret oncogene-induced cell differentiation in PC12 cells","volume":"275","year":"2000","journal-title":"J Biol Chem"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B66","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0092-8674(90)90150-D","article-title":"The GAP-related domain of the neurofibromatosis type 1 gene product interacts with ras p21","volume":"63","year":"1990","journal-title":"Cell"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B67","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1074\/jbc.275.5.3568","article-title":"Transforming ability of MEN2A-RET requires activation of the phosphatidylinositol 3-kinase\/AKT signaling pathway","volume":"275","year":"2000","journal-title":"J Biol Chem"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B68","doi-asserted-by":"crossref","first-page":"2428","DOI":"10.1093\/hmg\/ddt638","article-title":"The tumor susceptibility gene TMEM127 is mutated in renal cell carcinomas and modulates endolysosomal function","volume":"23","year":"2014","journal-title":"Hum Mol Genet"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B69","doi-asserted-by":"crossref","first-page":"2828","DOI":"10.1158\/1078-0432.CCR-12-0160","article-title":"MAX mutations cause hereditary and sporadic pheochromocytoma and paraganglioma","volume":"18","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B70","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-4257","article-title":"Somatic mutations in H-RAS in sporadic pheochromocytoma and paraganglioma identified by exome sequencing","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B71","doi-asserted-by":"crossref","first-page":"6044","DOI":"10.1038\/ncomms7044","article-title":"Multi-omics analysis defines core genomic alterations in pheochromocytomas and paragangliomas","volume":"6","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B72","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1158\/1078-0432.CCR-15-1841","article-title":"Recurrent mutations of chromatin-remodeling genes and kinase receptors in pheochromocytomas and paragangliomas","volume":"22","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B73","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1101\/gad.1648608","article-title":"The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor","volume":"22","year":"2008","journal-title":"Genes Dev"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B74","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/path.4503","article-title":"The genomic landscape of phaeochromocytoma","volume":"236","year":"2015","journal-title":"J Pathol"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B75","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.ccell.2016.04.002","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"29","author":"Cancer Genome Atlas Research Network","year":"2016","journal-title":"Cancer Cell"},{"issue":"7484","key":"key\n\t\t\t\t20171205135818_B76","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","year":"2014","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171205135818_B77","doi-asserted-by":"crossref","first-page":"6140","DOI":"10.1038\/ncomms7140","article-title":"Whole-exome sequencing identifies somatic ATRX mutations in pheochromocytomas and paragangliomas","volume":"6","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B78","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1002\/gcc.22267","article-title":"Whole-exome sequencing defines the mutational landscape of pheochromocytoma and identifies KMT2D as a recurrently mutated gene","volume":"54","year":"2015","journal-title":"Genes Chromosomes Cancer"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B79","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1530\/ERC-13-0429","article-title":"Telomerase reverse transcriptase promoter mutations in tumors originating from the adrenal gland and extra-adrenal paraganglia","volume":"21","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B80","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/joim.12507","article-title":"Precision medicine in pheochromocytoma and paraganglioma: current and future concepts","volume":"280","year":"2016","journal-title":"J Intern Med"},{"issue":"19","key":"key\n\t\t\t\t20171205135818_B81","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1158\/1078-0432.CCR-14-2854","article-title":"Spatiotemporal heterogeneity characterizes the genetic landscape of pheochromocytoma and defines early events in tumorigenesis","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B82","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1158\/2159-8290.CD-13-0092","article-title":"Succinate dehydrogenase mutation underlies global epigenomic divergence in gastrointestinal stromal tumor","volume":"3","year":"2013","journal-title":"Cancer Discov"},{"issue":"13","key":"key\n\t\t\t\t20171205135818_B83","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1158\/1078-0432.CCR-14-2804","article-title":"DNA methylation profiling in pheochromocytoma and paraganglioma reveals diagnostic and prognostic markers","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20171205135818_B84","doi-asserted-by":"crossref","first-page":"44943","DOI":"10.1038\/srep44943","article-title":"Global DNA methylation analysis identifies two discrete clusters of pheochromocytoma with distinct genomic and genetic alterations","volume":"7","year":"2017","journal-title":"Sci Rep"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B85","first-page":"72","article-title":"A HIF1alpha regulatory loop links hypoxia and mitochondrial signals in pheochromocytomas","volume":"1","year":"2005","journal-title":"PLoS Genet"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B86","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1677\/erc.1.00838","article-title":"Distinct gene expression profiles in norepinephrine- and epinephrine-producing hereditary and sporadic pheochromocytomas: activation of hypoxia-driven angiogenic pathways in von Hippel\u2013Lindau syndrome","volume":"11","year":"2004","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B87","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.humpath.2014.11.012","article-title":"Increased SSTR2A and SSTR3 expression in succinate dehydrogenase-deficient pheochromocytomas and paragangliomas","volume":"46","year":"2015","journal-title":"Hum Pathol"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B88","first-page":"1837","article-title":"Molecular and pharmacological characterization of somatostatin receptor subtypes in adrenal, extraadrenal, and malignant pheochromocytomas","volume":"80","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B89","first-page":"1082","article-title":"In vitro and in vivo detection of somatostatin receptors in pheochromocytomas and paragangliomas","volume":"74","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"issue":"17","key":"key\n\t\t\t\t20171205135818_B90","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1158\/1078-0432.CCR-14-2751","article-title":"Superiority of [68Ga]-DOTATATE PET\/CT to other functional imaging modalities in the localization of SDHB-associated metastatic pheochromocytoma and paraganglioma","volume":"21","year":"2015","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20171205135818_B91","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","year":"2016","journal-title":"J Nucl Med"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B92","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1007\/s00259-016-3357-x","article-title":"PET\/CT comparing (68)Ga-DOTATATE and other radiopharmaceuticals and in comparison with CT\/MRI for the localization of sporadic metastatic pheochromocytoma and paraganglioma","volume":"43","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B93","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1754-9485.2011.02327.x","article-title":"High management impact of Ga-68 DOTATATE (GaTate) PET\/CT for imaging neuroendocrine and other somatostatin expressing tumours","volume":"56","year":"2012","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B94","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1210\/jc.2003-030262","article-title":"Somatostatin receptor subtypes in human pheochromocytoma: subcellular expression pattern and functional relevance for octreotide scintigraphy","volume":"88","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B95","first-page":"685","article-title":"[(123)I]metaiodobenzylguanidine and [(111)In]octreotide uptake in benign and malignant pheochromocytomas","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B96","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1677\/ERC-10-0211","article-title":"Catecholamine metabolomic and secretory phenotypes in phaeochromocytoma","volume":"18","year":"2010","journal-title":"Endocr Relat Cancer"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B97","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1210\/jc.2006-2315","article-title":"Clinical presentations, biochemical phenotypes, and genotype-phenotype correlations in patients with succinate dehydrogenase subunit B-associated pheochromocytomas and paragangliomas","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B98","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B99","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1373\/clinchem.2010.153320","article-title":"Measurements of plasma methoxytyramine, normetanephrine, and metanephrine as discriminators of different hereditary forms of pheochromocytoma","volume":"57","year":"2011","journal-title":"Clin Chem"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B100","doi-asserted-by":"crossref","first-page":"e99","DOI":"10.1136\/jmg.2003.011551","article-title":"The prevalence of SDHB, SDHC, and SDHD mutations in patients with head and neck paraganglioma and association of mutations with clinical features","volume":"41","year":"2004","journal-title":"J Med Genet"},{"issue":"20","key":"key\n\t\t\t\t20171205135818_B101","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1158\/1078-0432.CCR-16-0606","article-title":"Pheochromocytoma: the first metabolic endocrine cancer","volume":"22","year":"2016","journal-title":"Clin Cancer Res"},{"key":"key\n\t\t\t\t20171205135818_B102","doi-asserted-by":"crossref","first-page":"8784","DOI":"10.1038\/ncomms9784","article-title":"Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism","volume":"6","year":"2015","journal-title":"Nat Commun"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B103","doi-asserted-by":"crossref","first-page":"e7094","DOI":"10.1371\/journal.pone.0007094","article-title":"The Warburg effect is genetically determined in inherited pheochromocytomas","volume":"4","year":"2009","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171205135818_B104","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2967\/jnumed.114.137034","article-title":"Correlation between in vivo 18F-FDG PET and immunohistochemical markers of glucose uptake and metabolism in pheochromocytoma and paraganglioma","volume":"55","year":"2014","journal-title":"J Nucl Med"},{"issue":"16","key":"key\n\t\t\t\t20171205135818_B105","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","year":"2007","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171205135818_B106","doi-asserted-by":"crossref","unstructured":"Lam AK . Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017.","DOI":"10.1007\/s12022-017-9484-5"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1023\/A:1011572617314","article-title":"Understanding catecholamine metabolism as a guide to the biochemical diagnosis of pheochromocytoma","volume":"2","year":"2001","journal-title":"Rev Endocr Metab Disord"},{"issue":"9486","key":"key\n\t\t\t\t20171205135818_B108","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/S0140-6736(05)67139-5","article-title":"Phaeochromocytoma","volume":"366","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B109","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1210\/jcem.86.5.7496","article-title":"Pheochromocytomas in von Hippel\u2013Lindau syndrome and multiple endocrine neoplasia type 2 display distinct biochemical and clinical phenotypes","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B110","volume-title":"WHO Classification of Tumours: Pathology and Genetics of Tumours of Endocrine Organs.","year":"2017","edition":"4th ed."},{"key":"key\n\t\t\t\t20171205135818_B111","volume-title":"Pathology and Genetics of Tumours of Endocrine Organs (IARC\/World Health Organization Classification of Tumours)","year":"2004"},{"key":"key\n\t\t\t\t20171205135818_B112","first-page":"919","volume-title":"AJCC Cancer Staging Manual","year":"2016","edition":"8th ed."},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B113","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1097\/MED.0000000000000330","article-title":"Malignant pheochromocytoma\u2013paraganglioma: pathogenesis, TNM staging, and current clinical trials","volume":"24","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B114","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1373\/clinchem.2014.224832","article-title":"Laboratory evaluation of pheochromocytoma and paraganglioma","volume":"60","year":"2014","journal-title":"Clin Chem"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B115","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice Guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Guideline Working Group","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B116","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.185","article-title":"Consensus Statement on next-generation-sequencing-based diagnostic testing of hereditary phaeochromocytomas and paragangliomas","volume":"13","year":"2017","journal-title":"Nat Rev Endocrinol"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B117","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B118","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/eci.12245","article-title":"Clinical utility of chromogranin A in SDHx-related paragangliomas","volume":"44","year":"2014","journal-title":"Eur J Clin Invest"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00005792-199101000-00003","article-title":"Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma","volume":"70","year":"1991","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B120","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1210\/jcem.87.5.8446","article-title":"Utility of plasma free metanephrines for detecting childhood pheochromocytoma","volume":"87","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B121","first-page":"1427","article-title":"Biochemical diagnosis of pheochromocytoma: which test is best","volume":"287","year":"2002","journal-title":"JAMA"},{"issue":"24","key":"key\n\t\t\t\t20171205135818_B122","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.1056\/NEJM199906173402404","article-title":"Plasma normetanephrine and metanephrine for detecting pheochromocytoma in von Hippel\u2013Lindau disease and multiple endocrine neoplasia type 2","volume":"340","year":"1999","journal-title":"N Engl J Med"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B123","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/j.1365-2796.2004.01425.x","article-title":"Biochemical diagnosis, localization and management of pheochromocytoma: focus on multiple endocrine neoplasia type 2 in relation to other hereditary syndromes and sporadic forms of the tumour","volume":"257","year":"2005","journal-title":"J Intern Med"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B124","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2008-1093","article-title":"Biochemically silent abdominal paragangliomas in patients with mutations in the succinate dehydrogenase subunit B gene","volume":"93","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B125","doi-asserted-by":"crossref","first-page":"4346","DOI":"10.1210\/jc.2013-1844","article-title":"Normotensive incidentally discovered pheochromocytomas display specific biochemical, cellular, and molecular characteristics","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B126","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1002\/ijc.28868","article-title":"Opposing effects of HIF1alpha and HIF2alpha on chromaffin cell phenotypic features and tumor cell proliferation: insights from MYC-associated factor X","volume":"135","year":"2014","journal-title":"Int J Cancer"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B127","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ydbio.2006.07.010","article-title":"The sympathoadrenal cell lineage: specification, diversification, and new perspectives","volume":"298","year":"2006","journal-title":"Dev Biol"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B128","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0031-6997(25)07245-X","article-title":"Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines","volume":"18","year":"1966","journal-title":"Pharmacol Rev"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B129","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/EJE-14-0756","article-title":"Lack of utility of SDHB mutation testing in adrenergic metastatic phaeochromocytoma","volume":"172","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"key\n\t\t\t\t20171205135818_B130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-14-523","article-title":"The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study","volume":"14","year":"2014","journal-title":"BMC Cancer"},{"key":"key\n\t\t\t\t20171205135818_B131","first-page":"50P","article-title":"The specific action of L-dopa decarboxylase","volume":"96","year":"1939","journal-title":"J Physiol"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B132","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/ajcp\/72.2.175","article-title":"Deficiency of dopamine-beta-hydroxylase. A new mechanism for normotensive pheochromocytomas","volume":"72","year":"1979","journal-title":"Am J Clin Pathol"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B133","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1210\/jcem.83.6.4870","article-title":"Plasma metanephrines are markers of pheochromocytoma produced by catechol-O-methyltransferase within tumors","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B134","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1016\/j.ejca.2011.07.016","article-title":"Plasma methoxytyramine: a novel biomarker of metastatic pheochromocytoma and paraganglioma in relation to established risk factors of tumour size, location and SDHB mutation status","volume":"48","year":"2012","journal-title":"Eur J Cancer"},{"issue":"26","key":"key\n\t\t\t\t20171205135818_B135","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJM197706302962609","article-title":"The triad of gastric leiomyosarcoma, functioning extra-adrenal paraganglioma and pulmonary chondroma","volume":"296","year":"1977","journal-title":"N Engl J Med"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B136","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1056\/NEJMc071191","article-title":"Familial gastrointestinal stromal tumors and germ-line mutations","volume":"357","author":"International Carney Triad and Carney-Stratakis Syndrome Consortium","year":"2007","journal-title":"N Engl J Med"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B137","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaoncol.2016.0256","article-title":"Molecular subtypes of KIT\/PDGFRA wild-type gastrointestinal stromal tumors: a report from the National Institutes of Health Gastrointestinal Stromal Tumor Clinic","volume":"2","year":"2016","journal-title":"JAMA Oncol"},{"issue":"268","key":"key\n\t\t\t\t20171205135818_B138","doi-asserted-by":"crossref","first-page":"268ra177","DOI":"10.1126\/scitranslmed.3009961","article-title":"Recurrent epimutation of SDHC in gastrointestinal stromal tumors","volume":"6","year":"2014","journal-title":"Sci Transl Med"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B139","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1530\/ERC-14-0254","article-title":"Aberrant DNA hypermethylation of SDHC: a novel mechanism of tumor development in Carney triad","volume":"21","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20171205135818_B140","doi-asserted-by":"crossref","unstructured":"Bausch B , SchiaviF, NiY, WelanderJ, PatocsA, NgeowJ, WellnerU, MalinocA, TaschinE, BarbonG, LanzaV, S\u00f6derkvistP, StenmanA, LarssonC, SvahnF, ChenJL, MarquardJ, FraenkelM, WalterMA, PeczkowskaM, PrejbiszA, JarzabB, Hasse-LazarK, PetersennS, MoellerLC, MeyerA, ReischN, TrupkaA, BraseC, GalianoM, PreussSF, KwokP, LendvaiN, BerishaG, Makay\u00d6, BoedekerCC, WeryhaG, RaczK, JanuszewiczA, WalzMK, GimmO, OpocherG, EngC, NeumannHP; European-American-Asian Pheochromocytoma-Paraganglioma Registry Study Group. Clinical characterization of the pheochromocytoma and paraganglioma susceptibility genes SDHA, TMEM127, MAX, and SDHAF2 for gene-informed prevention. JAMA Oncol. 2017.","DOI":"10.1001\/jamaoncol.2017.0223"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B141","doi-asserted-by":"crossref","first-page":"L43","DOI":"10.1530\/ERC-17-0030","article-title":"SDHA mutated paragangliomas may be at high risk of metastasis","volume":"24","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B142","doi-asserted-by":"crossref","first-page":"E1472","DOI":"10.1210\/jc.2011-1043","article-title":"SDHA immunohistochemistry detects germline SDHA gene mutations in apparently sporadic paragangliomas and pheochromocytomas","volume":"96","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B143","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnci\/djr130","article-title":"SDHA loss-of-function mutations in KIT-PDGFRA wild-type gastrointestinal stromal tumors identified by massively parallel sequencing","volume":"103","year":"2011","journal-title":"J Natl Cancer Inst"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B144","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B145","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/humu.21136","article-title":"Tumor risks and genotype\u2013phenotype\u2013proteotype analysis in 358 patients with germline mutations in SDHB and SDHD","volume":"31","year":"2010","journal-title":"Hum Mutat"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B146","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/humu.21269","article-title":"Are we overestimating the penetrance of mutations in SDHB","volume":"31","year":"2010","journal-title":"Hum Mutat"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B147","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/cge.12591","article-title":"Low penetrance of paraganglioma and pheochromocytoma in an extended kindred with a germline SDHB exon 3 deletion","volume":"89","year":"2016","journal-title":"Clin Genet"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B148","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1399-0004.2009.01157.x","article-title":"Penetrance and clinical consequences of a gross SDHB deletion in a large family","volume":"75","year":"2009","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20171205135818_B149","doi-asserted-by":"crossref","unstructured":"Rijken JA , NiemeijerND, JonkerMA, EijkelenkampK, JansenJC, van BerkelA, KunstHPM, BisschopP, KerstensMN, DreijerinkKMA, van DoorenMF, van der Horst-SchriversANA, HesFJ, Rene LeemansC, CorssmitEPM, HensenEF. The penetrance of paraganglioma and pheochromocytoma in SDHB germline mutation carriers. Clin Genet. 2017.","DOI":"10.1111\/cge.13055"},{"issue":"8","key":"key\n\t\t\t\t20171205135818_B150","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1007\/s00432-017-2397-3","article-title":"SDHB-related pheochromocytoma and paraganglioma penetrance and genotype-phenotype correlations","volume":"143","year":"2017","journal-title":"J Cancer Res Clin Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B151","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s100480050078","article-title":"PGL3, a third, not maternally imprinted locus in autosomal dominant paraganglioma","volume":"2","year":"1999","journal-title":"Neurogenetics"},{"key":"key\n\t\t\t\t20171205135818_B152","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1111\/j.1399-0004.2011.01653.x","article-title":"High prevalence of founder mutations of the succinate dehydrogenase genes in the Netherlands","volume":"81","year":"2012","journal-title":"Clin Genet"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B153","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1136\/jmg.2007.051045","article-title":"Genetic screening for pheochromocytoma: should SDHC gene analysis be included","volume":"44","year":"2007","journal-title":"J Med Genet"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B154","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/BF00569208","article-title":"Genetic aspects of nonchromaffin paraganglioma","volume":"60","year":"1982","journal-title":"Hum Genet"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B155","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(10)70007-3","article-title":"SDHAF2 mutations in familial and sporadic paraganglioma and phaeochromocytoma","volume":"11","year":"2010","journal-title":"Lancet Oncol"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B156","doi-asserted-by":"crossref","first-page":"E1392","DOI":"10.1210\/jc.2013-4536","article-title":"Universal genetic screening uncovers a novel presentation of an SDHAF2 mutation","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B157","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/ng849","article-title":"Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer","volume":"30","author":"Multiple Leiomyoma Consortium","year":"2002","journal-title":"Nat Genet"},{"key":"key\n\t\t\t\t20171205135818_B158","doi-asserted-by":"crossref","unstructured":"Muller M , FerlicotS, Guillaud-BatailleM, Le TeuffG, GenestieC, DeveauxS, SlamaA, PoulalhonN, EscudierB, AlbigesL, SoufirN, AvrilMF, GardieB, SaldanaC, AlloryY, Gimenez-RoqueploAP, Bressac-de PailleretsB, RichardS, BenusiglioPR. Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers. Clin Genet. 2017.","DOI":"10.1111\/cge.13014"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B159","doi-asserted-by":"crossref","first-page":"4498","DOI":"10.1210\/jc.2015-3045","article-title":"Pheochromocytoma screening initiation and frequency in von Hippel\u2013Lindau syndrome","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"18","key":"key\n\t\t\t\t20171205135818_B160","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1200\/JCO.2015.65.6140","article-title":"Von Hippel\u2013Lindau disease: genetics and role of genetic counseling in a multiple neoplasia syndrome","volume":"34","year":"2016","journal-title":"J Clin Oncol"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B161","doi-asserted-by":"crossref","first-page":"E908","DOI":"10.1210\/jc.2013-1217","article-title":"First report of bilateral pheochromocytoma in the clinical spectrum of HIF2A-related polycythemia\u2013paraganglioma syndrome","volume":"98","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B162","doi-asserted-by":"crossref","first-page":"E369","DOI":"10.1210\/jc.2013-2600","article-title":"Mosaicism in HIF2A-related polycythemia\u2013paraganglioma syndrome","volume":"99","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B163","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/ERC-16-0231","article-title":"Novel insights into the polycythemia\u2013paraganglioma\u2013somatostatinoma syndrome","volume":"23","year":"2016","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1399-0004.2010.01453.x","article-title":"RET codon 804 mutations in multiple endocrine neoplasia 2: genotype\u2013phenotype correlations and implications in clinical management","volume":"79","year":"2011","journal-title":"Clin Genet"},{"key":"key\n\t\t\t\t20171205135818_B165","first-page":"1736s","article-title":"The phenotypes associated with ret mutations in the multiple endocrine neoplasia type 2 syndrome","volume":"59","year":"1999","journal-title":"Cancer Res"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B166","doi-asserted-by":"crossref","first-page":"E308","DOI":"10.1210\/jc.2014-2473","article-title":"Penetrance and clinical features of pheochromocytoma in a six-generation family carrying a germline TMEM127 mutation","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"23","key":"key\n\t\t\t\t20171205135818_B167","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1001\/jama.2010.1830","article-title":"Spectrum and prevalence of FP\/TMEM127 gene mutations in pheochromocytomas and paragangliomas","volume":"304","year":"2010","journal-title":"JAMA"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B168","doi-asserted-by":"crossref","first-page":"T135","DOI":"10.1530\/ERC-15-0175","article-title":"15 years of paraganglioma: imaging and imaging-based treatment of pheochromocytoma and paraganglioma","volume":"22","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"key\n\t\t\t\t20171205135818_B169","article-title":"Functional imaging signature of patients presenting with polycythemia\/paraganglioma syndromes","volume-title":"J Nucl Med","year":"2017"},{"key":"key\n\t\t\t\t20171205135818_B170","first-page":"23","article-title":"Effectiveness and limits of preoperative imaging studies for the localisation of pheochromocytomas and paragangliomas: a review of 282 cases. French Association of Surgery (AFC), and The French Association of Endocrine Surgeons (AFCE)","volume":"164","year":"1998","journal-title":"Eur J Surg"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B171","first-page":"21","article-title":"Diagnosis and localization of pheochromocytoma. Detection by measurement of urinary norepinephrine excretion during sleep, plasma norepinephrine concentration and computerized axial tomography (CT-scan)","volume":"67","year":"1979","journal-title":"Am J Med"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B172","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1148\/radiology.186.3.8430179","article-title":"Pheochromocytomas that do not accumulate metaiodobenzylguanidine: localization with PET and administration of FDG","volume":"186","year":"1993","journal-title":"Radiology"},{"issue":"9","key":"key\n\t\t\t\t20171205135818_B173","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","year":"2012","journal-title":"J Natl Cancer Inst"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B174","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s11307-010-0396-8","article-title":"68Ga-DOTA-TATE PET vs. 123I-MIBG in identifying malignant neural crest tumours","volume":"13","year":"2011","journal-title":"Mol Imaging Biol"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B175","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1210\/jc.2012-2975","article-title":"Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL","volume":"98","author":"EVA Investigators","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B176","doi-asserted-by":"crossref","first-page":"448","DOI":"10.7150\/thno.3931","article-title":"Molecular imaging radiotherapy: theranostics for personalized patient management of neuroendocrine tumors (NETs)","volume":"2","year":"2012","journal-title":"Theranostics"},{"key":"key\n\t\t\t\t20171205135818_B177","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-3-642-59587-5_1","article-title":"The role of radioactive somatostatin and its analogues in the control of tumor growth","volume":"153","year":"2000","journal-title":"Recent Results Cancer Res"},{"issue":"suppl 2","key":"key\n\t\t\t\t20171205135818_B178","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1093\/annonc\/10.suppl_2.S23","article-title":"Radiolabelled somatostatin analogue(s) for peptide receptor scintigraphy and radionuclide therapy","volume":"10","year":"1999","journal-title":"Ann Oncol"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B179","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of (177)Lu-Dotatate for midgut neuroendocrine tumors","volume":"376","author":"NETTER-1 Trial Investigators","year":"2017","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20171205135818_B180","doi-asserted-by":"crossref","unstructured":"Brabander T , van der ZwanWA, TeunissenJJM, KamBLR, FeeldersRA, de HerderWW, van EijckCHJ, FranssenGJH, KrenningEP, KwekkeboomDJ. Long-term efficacy, survival, and safety of [177Lu-DOTA0,Tyr3]octreotate in patients with gastroenteropancreatic and bronchial neuroendocrine tumors. Clin Cancer Res. doi:10.1158\/1078-0432.CCR-16-2743","DOI":"10.1158\/1078-0432.CCR-16-2743"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B181","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00259-014-2893-5","article-title":"Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors","volume":"42","year":"2015","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20171205135818_B182","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1210\/jc.2004-1398","article-title":"Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma","volume":"90","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B183","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0039-6060(05)80118-7","article-title":"Surgical strategy for pheochromocytoma: emphasis on the pledge of flank extraperitoneal approach in selected patients","volume":"118","year":"1995","journal-title":"Surgery"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B184","doi-asserted-by":"crossref","first-page":"R135","DOI":"10.1530\/EJE-16-0189","article-title":"Management of endocrine disease: recurrence or new tumors after complete resection of pheochromocytomas and paragangliomas: a systematic review and meta-analysis","volume":"175","year":"2016","journal-title":"Eur J Endocrinol"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B185","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.surg.2016.05.050","article-title":"SDHB mutation status and tumor size but not tumor grade are important predictors of clinical outcome in pheochromocytoma and abdominal paraganglioma","volume":"161","year":"2017","journal-title":"Surgery"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B186","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1097\/00000478-200205000-00002","article-title":"Pheochromocytoma of the Adrenal Gland Scaled Score (PASS) to separate benign from malignant neoplasms: a clinicopathologic and immunophenotypic study of 100 cases","volume":"26","year":"2002","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B187","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/ERC-13-0494","article-title":"Pathological grading for predicting metastasis in phaeochromocytoma and paraganglioma","volume":"21","author":"Phaeochromocytoma Study Group in Japan","year":"2014","journal-title":"Endocr Relat Cancer"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B188","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/nrendo.2014.41","article-title":"Neuroendocrine cancer. Closing the GAPP on predicting metastases","volume":"10","year":"2014","journal-title":"Nat Rev Endocrinol"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B189","first-page":"1480","article-title":"Factors associated with perioperative morbidity and mortality in patients with pheochromocytoma: analysis of 165 operations at a single center","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B190","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1097\/00000658-199906000-00001","article-title":"Clinical experience over 48 years with pheochromocytoma","volume":"229","year":"1999","journal-title":"Ann Surg"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B191","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B192","first-page":"1208","article-title":"Long-term effect of adrenalectomy on cardiovascular remodeling in patients with pheochromocytoma","volume":"102","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B193","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","year":"2014","journal-title":"Lancet Oncol"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B194","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.surg.2006.07.039","article-title":"Posterior retroperitoneoscopic adrenalectomy: results of 560 procedures in 520 patients","volume":"140","year":"2006","journal-title":"Surgery"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B195","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0194599815627667","article-title":"Head and neck paragangliomas: an update on evaluation and management","volume":"154","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B196","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2014.02.010","article-title":"Treatment of head and neck paragangliomas with external beam radiation therapy","volume":"89","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"key\n\t\t\t\t20171205135818_B197","first-page":"166","article-title":"External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma","volume":"4","year":"2014","journal-title":"Front Oncol"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B198","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.2013-1907","article-title":"One-year progression-free survival of therapy-naive patients with malignant pheochromocytoma and paraganglioma","volume":"98","author":"French group of Endocrine and Adrenal Tumors (Groupe des Tumeurs Endocrines-Reseau National des Tumeurs Endocrines and Cortico-Medullo Tumeurs Endocrines networks)","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B199","unstructured":"Hamidi O , YoungWF, Jr, I\u00f1iguez-ArizaNM, KittahNE, GruberL, BancosC, TamhaneS, BancosI. Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years. J Clin Endocrinol Metab."},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B200","doi-asserted-by":"crossref","first-page":"e68","DOI":"10.1158\/1078-0432.CCR-17-0547","article-title":"Von Hippel\u2013Lindau and hereditary pheochromocytoma\/paraganglioma syndromes: clinical features, genetics, and surveillance recommendations in childhood","volume":"23","year":"2017","journal-title":"Clin Cancer Res"},{"issue":"25","key":"key\n\t\t\t\t20171205135818_B201","doi-asserted-by":"crossref","first-page":"4162","DOI":"10.1200\/JCO.2008.21.3496","article-title":"Phase II study of high-dose [131I]metaiodobenzylguanidine therapy for patients with metastatic pheochromocytoma and paraganglioma","volume":"27","year":"2009","journal-title":"J Clin Oncol"},{"key":"key\n\t\t\t\t20171205135818_B202","first-page":"284","article-title":"Treatment of malignant pheochromocytoma with [131I]metaiodobenzylguanidine: a French multicenter study","volume":"35","year":"1991","journal-title":"J Nucl Biol Med"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B203","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/BF03348026","article-title":"The treatment of malignant pheochromocytoma with iodine-131 metaiodobenzylguanidine (131I-MIBG): a comprehensive review of 116 reported patients","volume":"20","year":"1997","journal-title":"J Endocrinol Invest"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B204","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1089\/cbr.2009.0695","article-title":"Comparison of high-specific-activity ultratrace 123\/131I-MIBG and carrier-added 123\/131I-MIBG on efficacy, pharmacokinetics, and tissue distribution","volume":"25","year":"2010","journal-title":"Cancer Biother Radiopharm"},{"key":"key\n\t\t\t\t20171205135818_B205"},{"key":"key\n\t\t\t\t20171205135818_B206","first-page":"1599","article-title":"Effects of therapy with [177Lu-DOTA0, Tyr3]octreotate in patients with paraganglioma, meningioma, small cell lung carcinoma, and melanoma","volume":"47","year":"2006","journal-title":"J Nucl Med"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B207","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1055\/s-0032-1311637","article-title":"Peptide receptor radionuclide therapy (PRRT) with 177Lu-DOTATATE in individuals with neck or mediastinal paraganglioma (PGL)","volume":"44","year":"2012","journal-title":"Horm Metab Res"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B208","first-page":"334","article-title":"Radiolabeled DOTATOC in patients with advanced paraganglioma and pheochromocytoma","volume":"52","year":"2008","journal-title":"Q J Nucl Med Mol Imaging"},{"key":"key\n\t\t\t\t20171205135818_B209","unstructured":"Kong G , Grozinsky-GlasbergS, HofmanMS, CallahanJ, MeirovitzA, MaimonO, PattisonDA, GrossDJ, HicksRJ. Efficacy of peptide receptor radionuclide therapy (PRRT) for functional metastatic paraganglioma and phaeochromocytoma. J Clin Endocrinol Metab."},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B210","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","article-title":"Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis","volume":"81","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B211","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine","volume":"109","year":"1988","journal-title":"Ann Intern Med"},{"issue":"8","key":"key\n\t\t\t\t20171205135818_B212","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.23812","article-title":"Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients","volume":"113","year":"2008","journal-title":"Cancer"},{"key":"key\n\t\t\t\t20171205135818_B213","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","year":"2014","journal-title":"Int J Cancer"},{"key":"key\n\t\t\t\t20171205135818_B214","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1210\/jc.2012-2356","article-title":"Treatment with sunitinib for patients with progressive metastatic pheochromocytomas and sympathetic paragangliomas","volume":"97","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B215","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/s12020-017-1359-5","article-title":"Phase II trial of pazopanib in advanced\/progressive malignant pheochromocytoma and paraganglioma","volume":"57","year":"2017","journal-title":"Endocrine"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B216","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/jama.1997.03550010065042","article-title":"The diagnostic evaluation and multidisciplinary management of neurofibromatosis 1 and neurofibromatosis 2","volume":"278","year":"1997","journal-title":"JAMA"},{"issue":"12","key":"key\n\t\t\t\t20171205135818_B217","doi-asserted-by":"crossref","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","article-title":"Guidelines for diagnosis and therapy of MEN type 1 and type 2","volume":"86","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"key\n\t\t\t\t20171205135818_B218","unstructured":"Nationella rekommendationer f\u00f6r genetisk utredning av paragangliom\/ feokromocytom samt kontrollprogram f\u00f6r friska anlagsb\u00e4rare av ett anlag i SDHx-, TMEM127 och MAX-generna. http:\/\/sfmg.se\/download\/riktlinjer\/Cancergenetik\/Arftligt-feokromocytom-paragangliom_170627.pdf."},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B219","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s10689-013-9639-6","article-title":"Role of rapid sequence whole-body MRI screening in SDH-associated hereditary paraganglioma families","volume":"13","year":"2014","journal-title":"Fam Cancer"},{"issue":"328","key":"key\n\t\t\t\t20171205135818_B220","doi-asserted-by":"crossref","first-page":"328ra28","DOI":"10.1126\/scitranslmed.aac8228","article-title":"ATRX loss promotes tumor growth and impairs nonhomologous end joining DNA repair in glioma","volume":"8","year":"2016","journal-title":"Sci Transl Med"},{"issue":"18","key":"key\n\t\t\t\t20171205135818_B221","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1056\/NEJMoa1506859","article-title":"DNA-repair defects and olaparib in metastatic prostate cancer","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"6219","key":"key\n\t\t\t\t20171205135818_B222","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1126\/science.1257216","article-title":"Alternative lengthening of telomeres renders cancer cells hypersensitive to ATR inhibitors","volume":"347","year":"2015","journal-title":"Science"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B223","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1158\/1078-0432.CCR-15-1576","article-title":"In vivo detection of succinate by magnetic resonance spectroscopy as a hallmark of SDHx mutations in paraganglioma","volume":"22","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B224","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.neo.2014.10.010","article-title":"Metabolome profiling by HRMAS NMR spectroscopy of pheochromocytomas and paragangliomas detects SDH deficiency: clinical and pathophysiological implications","volume":"17","year":"2015","journal-title":"Neoplasia"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B225","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1210\/en.2015-1476","article-title":"Inhibitory effect of the noncamptothecin topoisomerase I inhibitor LMP-400 on female mice models and human pheochromocytoma cells","volume":"156","year":"2015","journal-title":"Endocrinology"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B226","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nchembio.1185","article-title":"Allosteric inhibition of hypoxia inducible factor-2 with small molecules","volume":"9","year":"2013","journal-title":"Nat Chem Biol"},{"issue":"10","key":"key\n\t\t\t\t20171205135818_B227","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/nm.1873","article-title":"The succinate receptor GPR91 in neurons has a major role in retinal angiogenesis","volume":"14","year":"2008","journal-title":"Nat Med"},{"issue":"51","key":"key\n\t\t\t\t20171205135818_B228","doi-asserted-by":"crossref","first-page":"85306","DOI":"10.18632\/oncotarget.13301","article-title":"Sunitinib for the treatment of benign and malignant neoplasms from von Hippel\u2013Lindau disease: a single-arm, prospective phase II clinical study from the PREDIR group","volume":"7","year":"2016","journal-title":"Oncotarget"},{"issue":"18","key":"key\n\t\t\t\t20171205135818_B229","doi-asserted-by":"crossref","first-page":"5218","DOI":"10.1158\/1078-0432.CCR-13-0491","article-title":"The role of aberrant VHL\/HIF pathway elements in predicting clinical outcome to pazopanib therapy in patients with metastatic clear-cell renal cell carcinoma","volume":"19","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"6","key":"key\n\t\t\t\t20171205135818_B230","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1080\/02841860701441848","article-title":"Peptide receptor radionuclide therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours","volume":"46","year":"2007","journal-title":"Acta Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B231","first-page":"266","article-title":"First clinical data on 68Ga-labeled somatostatin receptor antagonists: a phase I\/II study comparing 68Ga-OPS202 with 68Ga-DOTATOC PET\/CT","volume":"56","year":"2015","journal-title":"J Nucl Med"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B232","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.1007\/s00259-014-2857-9","article-title":"213Bi-DOTATOC receptor-targeted alpha-radionuclide therapy induces remission in neuroendocrine tumours refractory to beta radiation: a first-in-human experience","volume":"41","year":"2014","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B233","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1056\/NEJMoa1213755","article-title":"Alpha emitter radium-223 and survival in metastatic prostate cancer","volume":"369","author":"ALSYMPCA Investigators","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B234","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"CLARINET Investigators","year":"2014","journal-title":"N Engl J Med"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B235","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1210\/en.2015-1965","article-title":"Pasireotide therapy of multiple endocrine neoplasia type 1\u2013associated neuroendocrine tumors (NETs) in female mice deleted for an Men1 allele improves survival and reduces tumor progression","volume":"157","year":"2016","journal-title":"Endocrinology"},{"issue":"26","key":"key\n\t\t\t\t20171205135818_B236","doi-asserted-by":"crossref","first-page":"2550","DOI":"10.1056\/NEJMoa1605943","article-title":"Activity of selumetinib in neurofibromatosis type 1\u2013related plexiform neurofibromas","volume":"375","year":"2016","journal-title":"N Engl J Med"},{"issue":"24","key":"key\n\t\t\t\t20171205135818_B237","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1002\/cncr.30252","article-title":"Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer","volume":"122","year":"2016","journal-title":"Cancer"},{"issue":"21","key":"key\n\t\t\t\t20171205135818_B238","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1056\/NEJMoa1414428","article-title":"Nivolumab and ipilimumab versus ipilimumab in untreated melanoma","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B239","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non\u2013small-cell lung cancer","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"issue":"23","key":"key\n\t\t\t\t20171205135818_B240","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMoa1406498","article-title":"Genetic basis for clinical response to CTLA-4 blockade in melanoma","volume":"371","year":"2014","journal-title":"N Engl J Med"},{"issue":"6349","key":"key\n\t\t\t\t20171205135818_B241","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1126\/science.aan6733","article-title":"Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade","volume":"357","year":"2017","journal-title":"Science"},{"issue":"11","key":"key\n\t\t\t\t20171205135818_B242","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/gt.2011.54","article-title":"Oncolytic adenovirus modified with somatostatin motifs for selective infection of neuroendocrine tumor cells","volume":"18","year":"2011","journal-title":"Gene Ther"},{"issue":"7","key":"key\n\t\t\t\t20171205135818_B243","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1158\/2159-8290.CD-16-0146","article-title":"Personalized oncology meets immunology: the path toward precision immunotherapy","volume":"6","year":"2016","journal-title":"Cancer Discov"},{"issue":"2","key":"key\n\t\t\t\t20171205135818_B244","doi-asserted-by":"crossref","first-page":"L7","DOI":"10.1530\/ERC-16-0431","article-title":"Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma","volume":"24","year":"2017","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B245","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1053\/j.seminoncol.2016.01.005","article-title":"Precision oncology: a strategy we were not ready to deploy","volume":"43","year":"2016","journal-title":"Semin Oncol"},{"issue":"7387","key":"key\n\t\t\t\t20171205135818_B246","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature10868","article-title":"Unresponsiveness of colon cancer to BRAF(V600E) inhibition through feedback activation of EGFR","volume":"483","year":"2012","journal-title":"Nature"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B247","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ccell.2014.12.001","article-title":"Biological and therapeutic impact of intratumor heterogeneity in cancer evolution","volume":"27","year":"2015","journal-title":"Cancer Cell"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B248","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/path.4900","article-title":"Cousins not twins: intratumoural and intertumoural heterogeneity in syndromic neuroendocrine tumours","volume":"242","year":"2017","journal-title":"J Pathol"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B249","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/nrclinonc.2014.222","article-title":"Developing biomarker-specific end points in lung cancer clinical trials","volume":"12","year":"2015","journal-title":"Nat Rev Clin Oncol"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B250","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrclinonc.2015.204","article-title":"Computational oncology: mathematical modelling of drug regimens for precision medicine","volume":"13","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"issue":"1","key":"key\n\t\t\t\t20171205135818_B251","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1148\/radiol.2015150709","article-title":"Imaging in the age of precision medicine: summary of the proceedings of the 10th Biannual Symposium of the International Society for Strategic Studies in Radiology","volume":"279","year":"2016","journal-title":"Radiology"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B252","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1001\/jamaoncol.2015.1203","article-title":"Artificial intelligence, big data, and cancer","volume":"1","year":"2015","journal-title":"JAMA Oncol"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B253","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00439-003-0969-6","article-title":"Altitude is a phenotypic modifier in hereditary paraganglioma type 1: evidence for an oxygen-sensing defect","volume":"113","year":"2003","journal-title":"Hum Genet"},{"issue":"3","key":"key\n\t\t\t\t20171205135818_B254","first-page":"292","article-title":"The human carotid body at high altitudes","volume":"39","year":"1973","journal-title":"Pathol Microbiol (Basel)"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B255","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0046-8177(76)80052-4","article-title":"Chief cell hyperplasia in the human carotid body at high altitudes; physiologic and pathologic significance","volume":"7","year":"1976","journal-title":"Hum Pathol"},{"issue":"4","key":"key\n\t\t\t\t20171205135818_B256","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/jc.2014-3863","article-title":"Pheochromocytoma and paraganglioma in cyanotic congenital heart disease","volume":"100","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"issue":"5","key":"key\n\t\t\t\t20171205135818_B257","doi-asserted-by":"crossref","first-page":"e0127471","DOI":"10.1371\/journal.pone.0127471","article-title":"Oxygen concentration controls epigenetic effects in models of familial paraganglioma","volume":"10","year":"2015","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20171205135818_B258","first-page":"45","article-title":"Utility of the succinate: fumarate ratio for assessing SDH dysfunction in different tumor types","volume":"10","year":"2016","journal-title":"Mol Genet Metab Rep"}],"container-title":["Endocrine Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/edrv\/article-pdf\/38\/6\/489\/22189065\/er.2017-00062.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T16:37:11Z","timestamp":1750783031000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/edrv\/article\/38\/6\/489\/4064267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,4]]},"references-count":258,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2017,8,4]]},"published-print":{"date-parts":[[2017,12,1]]}},"URL":"https:\/\/doi.org\/10.1210\/er.2017-00062","relation":{},"ISSN":["0163-769X","1945-7189"],"issn-type":[{"value":"0163-769X","type":"print"},{"value":"1945-7189","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,12,1]]},"published":{"date-parts":[[2017,8,4]]}}}